Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Telmisartan 40mg
DRUG
4 trials
Sponsors
Boehringer Ingelheim
, Emory University
, Yuhan Corporation
, University of Hawaii
Conditions
Alzheimer's Disease
COVID-19
Chronic Kidney Disease
Hypertension
Proteinuria
Phase 1
Health Evaluation in African Americans Using RAS Therapy
Completed
NCT02471833
Emory University
Alzheimer's Disease
Start: 2015-04-30
End: 2022-04-15
Updated: 2024-05-23
Phase 2
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients
Terminated
NCT04360551
University of Hawaii
COVID-19
Start: 2020-07-01
End: 2022-04-26
Updated: 2023-08-21
Phase 4
HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria
NCT03550859
Yuhan Corporation
Chronic Kidney Disease, Proteinuria
Start: 2018-06-05
End: 2021-12-31
Target: 374
Updated: 2020-12-14
Unknown Phase
Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
Completed
NCT01050062
Boehringer Ingelheim
Hypertension
Start: 2010-01-31
End: 2011-12-31
Updated: 2014-05-01
Related Papers
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
2021-11-01
42 citations